Rallybio Corporation — Cash Flow (NASDAQ:RLYB) | MetaTrader

Open full chart

Financials

Overview Relevé Statistics Dividends

Quarterly Annual

Cash from operating activities 45.53 M57.28 M60.27 M49.28 M 35 M Cash from investing activities 2.33 M112.17 M27.66 M33.49 M 41.77 M Cash from financing activities 82.97 M51.08 M143 K5.2 M 28 K Free cash flow 45.2 M57.23 M60.25 M49.28 M 35 M

Nouvelles

Le directeur financier de Rallybio, Lieber, vend pour 3.992$ d’actions

Lieber, Rallybio CFO, sells $3992 in shares

Rallybio Partage des Résultats Prometteurs de la Phase Précoce pour un Médicament contre les Maladies Rares; Nouvel Essai Prévu pour Fin 2026 | Benzinga France

Rallybio reports positive phase 1 results for subcutaneous C5 inhibitor

Rallybio announces one-for-eight reverse stock split effective Feb 6

Upcoming Stock Splits This Week (February 2 to February 6) – Stay Invested - TipRanks.com

Rallybio va mettre en œuvre un regroupement d’actions à raison de 1 pour 8 à partir du 6 février

Rallybio to implement 1-for-8 reverse stock split effective February 6

Rallybio completes first cohort dosing in RLYB116 C5 inhibitor study

Here's Why Shares in Recursion Pharmaceuticals Surged Today

Recursion Pharmaceuticals stock soars after acquiring HPP treatment from Rallybio

Why Is Microcap Rallybio Stock Trading Higher On Tuesday? - Rallybio (NASDAQ:RLYB), Recursion Pharmaceuticals (NASDAQ:RXRX)